1. Home
  2. ZLAB vs KGS Comparison

ZLAB vs KGS Comparison

Compare ZLAB & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • KGS
  • Stock Information
  • Founded
  • ZLAB 2013
  • KGS 2011
  • Country
  • ZLAB China
  • KGS United States
  • Employees
  • ZLAB N/A
  • KGS N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • KGS
  • Sector
  • ZLAB Health Care
  • KGS
  • Exchange
  • ZLAB Nasdaq
  • KGS Nasdaq
  • Market Cap
  • ZLAB 3.0B
  • KGS 3.6B
  • IPO Year
  • ZLAB 2017
  • KGS 2023
  • Fundamental
  • Price
  • ZLAB $26.05
  • KGS $47.38
  • Analyst Decision
  • ZLAB Strong Buy
  • KGS Strong Buy
  • Analyst Count
  • ZLAB 3
  • KGS 11
  • Target Price
  • ZLAB $55.00
  • KGS $39.36
  • AVG Volume (30 Days)
  • ZLAB 482.4K
  • KGS 976.6K
  • Earning Date
  • ZLAB 02-25-2025
  • KGS 03-05-2025
  • Dividend Yield
  • ZLAB N/A
  • KGS 3.46%
  • EPS Growth
  • ZLAB N/A
  • KGS N/A
  • EPS
  • ZLAB N/A
  • KGS 0.26
  • Revenue
  • ZLAB $355,748,000.00
  • KGS $1,075,772,000.00
  • Revenue This Year
  • ZLAB $49.04
  • KGS $39.35
  • Revenue Next Year
  • ZLAB $46.70
  • KGS $16.29
  • P/E Ratio
  • ZLAB N/A
  • KGS $182.43
  • Revenue Growth
  • ZLAB 35.01
  • KGS 33.77
  • 52 Week Low
  • ZLAB $13.48
  • KGS $21.39
  • 52 Week High
  • ZLAB $36.60
  • KGS $47.73
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 50.14
  • KGS 74.09
  • Support Level
  • ZLAB $23.82
  • KGS $41.32
  • Resistance Level
  • ZLAB $25.64
  • KGS $44.43
  • Average True Range (ATR)
  • ZLAB 1.24
  • KGS 1.38
  • MACD
  • ZLAB 0.06
  • KGS 0.47
  • Stochastic Oscillator
  • ZLAB 64.45
  • KGS 95.53

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Compression Operations and Other Services. Compression Operations consist of operating company-owned and customer-owned compression infrastructure for customers, pursuant to fixed-revenue contracts to enable the production, gathering and transportation of natural gas and oil. Other Services consist of a full range of contract services to support the needs of customers, including station construction, maintenance and overhaul and other ancillary time and material-based offerings.

Share on Social Networks: